Streptococcus pneumoniae serotype 19A: worldwide epidemiology
R Isturiz, HL Sings, B Hilton, A Arguedas… - Expert review of …, 2017 - Taylor & Francis
Introduction: Streptococcus pneumoniae causes mucosal and invasive diseases with high
morbidity and mortality. Introduction of the 7-valent pneumococcal conjugate vaccine …
morbidity and mortality. Introduction of the 7-valent pneumococcal conjugate vaccine …
[HTML][HTML] Pneumococcal vaccination in children: a systematic review and meta-analysis of cost-effectiveness studies
Abstract Objectives Pneumococcal conjugate vaccines (PCVs) have significantly reduced
disease burden caused by Streptococcus pneumoniae, a leading cause of childhood …
disease burden caused by Streptococcus pneumoniae, a leading cause of childhood …
Trends in otitis media–related health care use in the United States, 2001-2011
Importance Otitis media (OM) is a leading cause of pediatric health care visits and the most
frequent reason children consume antibiotics or undergo surgery. During recent years …
frequent reason children consume antibiotics or undergo surgery. During recent years …
Early impact of sequential introduction of 7-valent and 13-valent pneumococcal conjugate vaccine on IPD in Israeli children< 5 years: an active prospective nationwide …
S Ben-Shimol, D Greenberg, N Givon-Lavi… - Vaccine, 2014 - Elsevier
Background The 7-valent pneumococcal conjugated vaccine (PCV7) was introduced to the
Israeli national immunization plan (NIP) in July 2009 (administered at age 2, 4 and 12 …
Israeli national immunization plan (NIP) in July 2009 (administered at age 2, 4 and 12 …
[HTML][HTML] Estimating the clinical and economic impact of switching from the 13-valent Pneumococcal Conjugate Vaccine (PCV13) to higher-valent options in Greek …
S Warren, M Barmpouni, V Kossyvaki, G Gourzoulidis… - Vaccines, 2023 - mdpi.com
In June 2010, Greece introduced the 13-valent pneumococcal conjugate vaccine (PCV13)
for pediatric vaccination and has since observed a large decrease in pneumococcal disease …
for pediatric vaccination and has since observed a large decrease in pneumococcal disease …
Prevalence and antibiotic resistance of commensal Streptococcus pneumoniae in nine European countries
RY Yahiaoui, CDJ den Heijer, EME van Bijnen… - Future …, 2016 - Taylor & Francis
The human microbiota represents an important reservoir of antibiotic resistance. Moreover,
the majority of antibiotics are prescribed in primary care. For this reason, we assessed the …
the majority of antibiotics are prescribed in primary care. For this reason, we assessed the …
[HTML][HTML] Cost-effectiveness analysis of routine use of 15-valent pneumococcal conjugate vaccine in the US pediatric population
This study evaluated the clinical and economic impact of routine pediatric vaccination with
the 15-valent pneumococcal conjugate vaccine (PCV15, V114) compared with the 13-valent …
the 15-valent pneumococcal conjugate vaccine (PCV15, V114) compared with the 13-valent …
[HTML][HTML] Pneumococcal disease: a systematic review of health utilities, resource use, costs, and economic evaluations of interventions
Background Pneumococcal diseases cause substantial mortality, morbidity, and economic
burden. Evidence on data inputs for economic evaluations of interventions targeting …
burden. Evidence on data inputs for economic evaluations of interventions targeting …
[HTML][HTML] Distribution of serotypes and patterns of antimicrobial resistance among commensal Streptococcus pneumoniae in nine European countries
RY Yahiaoui, HJ Bootsma, CDJ den Heijer… - BMC infectious …, 2018 - Springer
Background Streptococcus pneumoniae is a commensal of the human upper respiratory
tract and a major cause of morbidity and mortality worldwide. This paper presents the …
tract and a major cause of morbidity and mortality worldwide. This paper presents the …
Choosing between 7-, 10-and 13-valent pneumococcal conjugate vaccines in childhood: a review of economic evaluations (2006–2014)
DBC Wu, N Chaiyakunapruk, HY Chong, P Beutels - Vaccine, 2015 - Elsevier
Background Seven-valent pneumococcal conjugate vaccines (PCV7) have been used in
children for more than a decade. Given the observed increase in disease caused by …
children for more than a decade. Given the observed increase in disease caused by …